Skip to main content
. Author manuscript; available in PMC: 2016 May 26.
Published in final edited form as: Hepatology. 2008 Oct;48(4):1167–1174. doi: 10.1002/hep.22446

Table 3.

Comparison of Screening Tests for WD in ALF: 1Ceruloplasmin; 2Alkaline Phosphatase:Total Bilirubin; 3Not applicable; 4Serum Copper. In the chronic liver disease group, zero subjects had an AP:TB ratio < 4, three subjects had Hg <10, one had Cu >200, and the AST:ALT ratio was an ineffective marker of WD.

Group Screening Test Sensitivity % Specificity % Likelihood
Ratio
Acute: Cp1 (mg/dL)<20 by
oxidase
21 84 1
Cp (mg/dL) <20 by
nephelometry
56 63 2
Hemoglobin (g/dL) <10 94 74 4
AP:TB2 ratio <4 94 96 23
AP:TB ratio <4 +
AST:ALT ratio >2.2
100 100 NA3
Cu4 (μg/dL) >200 75 96 17
AST:ALT ratio >2.2 94 86 7
Chronic: Cp (mg/dL) <20 by
oxidase
71 97 21
Cp (mg/dL) <20 by
nephelometry
71 79 3